Purchase Order 75N95023P00311
Award Date 5/25/23
Potential Completion Date 5/24/24
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brunswick, ME 04011, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- This is a $90,414 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for a Liver Assay in Liver Spheroids to evaluate the toxicity of short interfering RNA (siRNA) and antisense oligonucleotides (ASOs), which are increasingly being used as...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $75,000.00 firm-fixed-price purchase order to Insphero Inc., a foreign-owned for-profit manufacturer of advanced 3D cell culture products. The contract is for safety assessment studies using Insphero's human, mouse, and rat 3D liver spheroid models to evaluate drug-induced liver injury (DILI) as part of the DILIPLUS assay program. This contract...
- Insphero, Inc. has been awarded a firm fixed price purchase order valued at twenty-two thousand eight hundred dollars from the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences. The contract calls for Insphero to provide 3D liver microtissues composed of human primary hepatocytes and liver cells for drug testing and safety assessments. Insphero will deliver the 3D liver spheroids to support drug-induced liver injury assays...
- This is a $24,061 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the foreign-owned, for-profit manufacturer Fujifilm Cellular Dynamics, Inc. The contract is for the supply of various induced pluripotent stem cell (iPSC)-derived human cell products, including cardiomyocytes, neurons, astrocytes, hepatocytes, and endothelial cells. These specialized cell lines are used in biomedical...
- This federal contract award, identified as HHSN271201600029C, was made by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $271,070.00, was awarded to Regenhu SA, doing business as Regenhu LTD, a for-profit manufacturer of bioprinting equipment and platforms. The contract is for the delivery of a 3D bioprinter and associated equipment to support research...
- This federal contract award is for the acquisition of an automatic cell culture station, including a liquid handler, thermoplate, incubator, and live cell imager, by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Cellink LLC, a foreign-owned, for-profit organization, on a firm-fixed price basis for a potential value of $151,928.00. The...
- This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The $241,459.53 contract is for the supply of various iPS cell-derived cell types, including dopaminergic, GABAergic, and glutamatergic neurons, as well as endothelial cells, to support the National Center for Advancing...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...